Neovasc Inc. is a Richmond, Canada medical device company developing the Shockwave Reducer to treat refractory angina.
Founded in 2008 and headquartered in Richmond, Canada, Neovasc Inc. develops medical devices for coronary artery disease, including the Shockwave Reducer for refractory angina. The company has raised a total of USD 72.00 mn and reported a valuation of USD 10.00 mn, and its latest round was an ADD-ON with Shockwave Medical, Inc. as an investor. In 2019 it reported revenue of USD 2.10 mn, and stakes previously held by Boston Scientific Corporation and Fidelity Investments were exited without disclosed financial terms.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in